Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:July 26, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:July 26, 2016Terminated
Condition(s):Renal Cell CarcinomaLast Updated:May 24, 2023Active, not recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 16, 2022Completed
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:June 21, 2019Terminated
Condition(s):Renal Cell CarcinomaLast Updated:July 17, 2017Withdrawn
Condition(s):Renal Cell Carcinoma; Adrenal CarcinomaLast Updated:February 12, 2021Unknown status
Condition(s):Renal Cell CarcinomaLast Updated:March 7, 2024Recruiting
Condition(s):Advanced Renal Cell Carcinoma; Renal Cell Carcinoma; Metastatic Renal Cell CarcinomaLast Updated:June 14, 2018Terminated
Condition(s):Advanced Renal Cell CarcinomaLast Updated:April 10, 2015Completed
Condition(s):Melanoma Stage Iv; Renal Cell Carcinoma, MetastaticLast Updated:December 5, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.